Below are the financial statements of Naspers, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2025 as of 2025-03-31 | 2024 as of 2024-03-31 |
|---|---|---|
| Non-current assets | 50,810a | 39,993a |
| Assets | — | — |
| Non-current assets | — | — |
| Property, plant and equipment | 724a | 764a |
| Goodwill | 1,218a | 1,094a |
| Post-employment medical asset | 14a | 0a |
| Other intangible assets | 402a | 335a |
| Investments in associates | 41,464a | 34,789a |
| Investments in joint ventures | 23a | 43a |
| Other investments | 6,593a | 2,538a |
| Financing receivables | 149a | 197a |
| Other receivables | 25a | 44a |
| Related party receivables | 176a | 167a |
| Deferred taxation | 22a | 22a |
| Current assets | 22,458a | 22,282a |
| Current assets | — | — |
| Inventory | 321a | 355a |
| Trade receivables | 241a | 310a |
| Financing receivables | 512a | 360a |
| Other receivables | 1,443a | 1,047a |
| Related party receivables | 19a | 27a |
| Derivative financial instruments | 1a | 0a |
| Other investments | 0a | 3,185a |
| Short-term investments | 11,913a | 13,834a |
| Cash and cash equivalents | 7,310a | 2,243a |
| Assets classified as held for sale | 698a | 921a |
| Total assets | 73,268a | 62,275a |
| Equity and liabilities | — | — |
| Capital and reserves attributable to the group’s equity holders | 22,185a | 17,872a |
| Capital and reserves attributable to the group’s equity holders | — | — |
| Share capital and premium | 4,611a | 4,611a |
| Treasury shares | -517a | -564a |
| Other reserves | -25,359a | -27,477a |
| Retained earnings | 43,450a | 41,302a |
| Non-controlling interests | 29,026a | 23,410a |
| Total equity | 51,211a | 41,282a |
| Non-current liabilities | 15,609a | 16,188a |
| Non-current liabilities | — | — |
| Post-employment medical liability | 15a | 14a |
| Long-term liabilities | 15,399a | 15,990a |
| Other non-current liabilities | 53a | 62a |
| Cash-settled share-based payment liability | 46a | 38a |
| Provisions | 4a | 5a |
| Deferred taxation | 92a | 79a |
| Current liabilities | 6,448a | 4,805a |
| Current liabilities | — | — |
| Current portion of long-term liabilities | 1,384a | 496a |
| Provisions | 63a | 64a |
| Trade payables | 365a | 427a |
| Accrued expenses | 2,610a | 1,875a |
| Other current liabilities | 965a | 688a |
| Cash-settled share-based payment liability | 366a | 474a |
| Related party payables | 5a | 4a |
| Taxation payable | 100a | 31a |
| Dividends payable | 2a | 2a |
| Derivative financial instruments | 28a | 1a |
| Bank overdrafts | 37a | 15a |
| Liabilities classified as held for sale | 523a | 728a |
| Total equity and liabilities | 73,268a | 62,275a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.